Skip to main content
Contact Us
Subscriber Sign In
navigation
サイト内検索
What We Do
Commercial Intelligence
Products
Evaluate Pharma
Evaluate Omnium
Evaluate Medtech
Evaluate Epi
Japan Drug Forecasts
Europe Drug Forecasts
CDMO Intelligence
Pharma Consulting & Analytics
Pharma Consulting & Analytics
Data Feeds
Evaluate Vantage
News
Analysis
Policy & Pricing
Insights
Events
Medtech
Therapy Areas
Evaluate for Biotech
How We Can Help You
Pharma and Biotech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
Multimedia
Blog
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Contact Us
Sign Up for Evaluate Vantage
Talent
Subscriber Sign In
Search
Open configuration options
Search
Vantage
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
Breadcrumb
Home
Vantage
Pharmaceutical Companies
Neurosearch
Evaluate
August 03, 2016
Therapy focus – One step forward but two steps back in Huntington’s
February 21, 2014
Glimmers of hope in Huntington's must not be overstated
May 22, 2013
Search continues for biomarkers to aid Huntington’s research
April 11, 2013
Therapeutic focus – Two steps back for Huntington’s disease
March 22, 2013
Genmab basks in Nordic glory
July 04, 2012
Obesity turnaround drives small cap gainers in H1
March 20, 2012
Therapeutic focus - Hopes fading for nicotinic receptors as Astra pill flunks
December 02, 2011
Scandinavian biotech hit particularly hard in bad year for sector
October 04, 2011
Pharmasset continues to lead small cap gainers so far in 2011
August 25, 2011
Most valuable unpartnered pipeline assets – what's hot and what's not
April 13, 2011
EP Vantage Interview - NeuroSearch seeking path forward for Huntexil
Load More
Latest Reports
July 27, 2023
H1 Round Up: The haves and the have-nots
July 21, 2023
ADA/EASL eBook
Editor's Picks
July 03, 2023
Astrazeneca and Daiichi’s big reveal disappoints
July 13, 2023
Pharma finds a way to gain weight
July 03, 2023
Protagonist investors flake as psoriasis pill disappoints
June 29, 2023
Approaching datasets for big pharma
June 27, 2023
Nkarta goes back to basics